<div class="description">
<p>Drug-induced gingival enlargement<br>Lieutenant Commander Craig K. Foisie, DC, USN and Captain Thu P. Getka, DC, USN<br><br>Introduction<br>Drug-induced gingival enlargement is classified by the American Academy of Periodontology as a dental plaque-induced gingival disease,  as evidence suggests that existing gingival inflammation may be necessary for its development and that proper plaque control and effective oral hygiene can lessen its severity or potentially prevent its occurrence altogether.  Currently, there are over 20 medications from three pharmaceutical categories including anticonvulsants, calcium channel blockers and immunosuppressants that are associated with gingival enlargement. It is the responsibility of the dental practitioner to recognize the potential of these medications to contribute to gingival enlargement and to provide the proper prophylactic care or appropriately refer the patient for periodontal therapy. A team approach involving a consultation with a periodontist and the patient’s physician is a critical step in successful treatment.
</p>
<br>Subjects: Gingival Hyperplasia; Gingival Overgrowth</div>
<div class="fn value">
U.S. Navy. Naval Postgraduate Dental School</div>
<dl><dd><a rel="nofollow" class="external free" href="https://archive.org/details/08006DrugInducedGingivalEnlargement">https://archive.org/details/08006DrugInducedGingivalEnlargement</a></dd>
<dd><a rel="nofollow" class="external free" href="https://archive.org/download/08006DrugInducedGingivalEnlargement/08_-_006_Drug-induced%20gingival%20enlargement.pdf">https://archive.org/download/08006DrugInducedGingivalEnlargement/08_-_006_Drug-induced%20gingival%20enlargement.pdf</a></dd></dl>